Feed aggregator
XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics Holdings, Inc. (NYSE: CWAN). Under the terms of the proposed transaction, shareholders of Enfusion will receive $5.85 in cash and $5.40 in Clearwater Class A Common Stock for each share of Enfusion that they own. KSF is seeking to determine whether this consi
INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Intra-Cellular Therapies, Inc. (NasdaqGS: ITCI) to Johnson & Johnson (NYSE: JNJ). Under the terms of the proposed transaction, shareholders of Intra-Cellular will receive $132.00 in cash for each share of Intra-Cellular that they own. KSF is seeking to determine whether this consideration and the process t
Shareholder Alert: Ademi LLP investigates whether Salarius Pharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Salarius (NASDAQ: SLRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Decoy Therapeutics. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the reverse merger transaction, Salarius stockholders would own only approximately 14% of the outstanding shares and
Kirby McInerney LLP Urges Investors in Dentsply Sirona Inc. (XRAY) to Inquire About Their Rights in Class Action Lawsuit
NEW YORK--(BUSINESS WIRE)---- $XRAY #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) securities between May 6, 2021, through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEARN MO
Shareholder Alert: Ademi LLP investigates whether Intra-Cellular Therapies, Inc. is obtaining a Fair Price for its Public Shareholders
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Intra-Cellular Therapies (Nasdaq: ITCI) for possible breaches of fiduciary duty and other violations of law in its transaction with Johnson & Johnson. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, Intra-Cellular Therapies stockholders will receive only $132.00 per share in cash
Atlantic Union Bankshares Corporation and Sandy Spring Bancorp, Inc. Announce Receipt of Federal Reserve Approvals to Complete Mergers
RICHMOND, Va. & OLNEY, Md.--(BUSINESS WIRE)--Atlantic Union Bankshares receives approval from Federal Reserve for Sandy Spring acquistion
Rosen Law Firm Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQ: TMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public. So What: If you purchased TransMedics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee
Barclays Bank PLC Amends Purchase Price of Certain Cash Tender Offers and Consent Solicitations
NEW YORK--(BUSINESS WIRE)--Barclays Bank PLC (the “Issuer”) announced today that, in connection with its previously announced cash tender offers (each, an “Offer”) to purchase any and all of its outstanding exchange-traded notes (the “Notes” or the “ETNs”) of four separate series (each, a “Series”) and the solicitation of consents (each, a “Consent Solicitation”) from holders of the Notes (the “Noteholders”) to amend certain provisions of the Notes with respect to each Series, it has amended th
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. with the Schall Law Firm
KBRA Assigns Rating to Blue Owl Technology Finance Corp.'s Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns a rating of BBB to Blue Owl Technology Finance Corp. ("OTF" or "the company") $650 million, 6.100% senior unsecured notes due March 15, 2028. The rating Outlook is Stable. Key Credit Considerations OTF benefits from its ties to the $128.4 billion Blue Owl Credit platform, with approximately $27 billion deployed into the technology strategy across all funds since inception. The experienced management team that has decades of experience working in the priva
Comstock Announces 3 New Leases at Loudoun Station
RESTON, Va.--(BUSINESS WIRE)--Comstock Holding Companies, Inc. (Nasdaq: CHCI) (“Comstock”), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the Washington, D.C. region, announced today the signing of the following three new retail leases at Loudoun Station, the county’s first and only Metro-connected mixed-use development: Dogtopia – 5,600 square feet Curry Pizza House – 2,000 square feet Hawaii Fluid Art – 1,600 square feet Dogtopia is the large
Sallie Mae Appoints Henry Greig to Its Board of Directors
NEWARK, Del.--(BUSINESS WIRE)--Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced the appointment of Henry Greig to its board of directors, effective January 12, 2025. Mr. Greig brings decades of industry experience in financial services, risk management, strategy, and operations to the Board. He held various positions at Synchrony Financial from 2014-2023, including Chief Credit Officer, Chief Risk Officer, and Executive Vice President. Prior to Synchrony Financial, he worked
Customers Bancorp, Inc. hosts Fourth Quarter and Full-Year 2024 Earnings Webcast Friday, Jan. 24, 2025
WEST READING, Pa.--(BUSINESS WIRE)---- $CUBI #Banking--CUSTOMERS BANCORP, INC. HOSTS FOURTH QUARTER AND FULL-YEAR 2024 EARNINGS WEBCAST
FRIDAY, JAN. 24, 2025
SBSB Eastham Founder John Schouest Named to 2025 Lawdragon 500 Leading Lawyers in America Guide
HOUSTON--(BUSINESS WIRE)--Schouest, Bamdas, Soshea, BenMaier & Eastham PLLC (SBSB Eastham) is pleased to announce that firm founder John Schouest has been named to the 2025 Lawdragon 500 Leading Lawyers list, a guide to the most exceptional lawyers in the country. “We are fiercely proud of this guide, the lawyers on it, the process that creates it and what it means: that being a great lawyer, a powerful lawyer is not just a plaque on the wall. It is an act of courage to never give up on beh
Jefferies to Hold Global Trading Day on January 16 to Support Los Angeles Wildfire Relief Efforts
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Jefferies announced today that it will hold a Global Trading Day on January 16, 2025, to raise funds for organizations supporting first responders and those impacted by the fires. Jefferies will donate 100% of net global commissions on January 16 for all trading in equities and fixed income by the Firm’s clients. Jefferies will also make a $1 million donation and encourage its nearly 6,000 employees to personally support relief efforts. During the
Principal Financial Group to Hold Combined Earnings and Outlook Call
DES MOINES, Iowa--(BUSINESS WIRE)--Principal Financial Group® (Nasdaq: PFG) announced today that it will release fourth quarter and full year 2024 financial results and the company’s outlook for 2025 after U.S. markets close on Thursday, February 6, 2025. On Friday, February 7, 2025, at 9 a.m. ET, Deanna Strable, president and chief executive officer, and Joel Pitz, interim chief financial officer, will discuss the results and the 2025 outlook during a live conference call. Additional members o
Rand Capital Corporation Announces Shareholder Election Results for Fourth Quarter 2024 Stock and Cash Dividend
BUFFALO, N.Y.--(BUSINESS WIRE)--Rand Capital Corporation (Nasdaq: RAND) Announces Shareholder Election Results for Fourth Quarter 2024 Stock and Cash Dividend
Dun & Bradstreet Receives TrustArc’s TRUSTe Responsible AI Certification, Reaffirming Company’s Commitment to Responsible AI
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Dun & Bradstreet (NYSE:DNB), a leading global provider of business decisioning data and analytics, announced today it has received TrustArc’s TRUSTe Responsible AI Certification for its strong commitment and adherence to responsible artificial intelligence (AI) governance. “At Dun & Bradstreet, our data is widely received and trusted by our clients because we prioritize ethical and responsible data and AI use across our business, applying our best pr
Brighthouse Financial Announces Conference Call to Discuss Fourth Quarter and Full Year 2024 Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. (Brighthouse Financial) (Nasdaq: BHF) announced today that it plans to hold a conference call and audio webcast to discuss its financial results for the fourth quarter and full year ended December 31, 2024, at 8:00 a.m. Eastern Time on Wednesday, February 12, 2025. The call will follow the issuance of the Brighthouse Financial fourth quarter and full year 2024 earnings release and financial supplement on Tuesday, February 11, 2025, a